PL2509637T3 - Sposób oczyszczania - Google Patents

Sposób oczyszczania

Info

Publication number
PL2509637T3
PL2509637T3 PL10766453.4T PL10766453T PL2509637T3 PL 2509637 T3 PL2509637 T3 PL 2509637T3 PL 10766453 T PL10766453 T PL 10766453T PL 2509637 T3 PL2509637 T3 PL 2509637T3
Authority
PL
Poland
Prior art keywords
purification method
purification
Prior art date
Application number
PL10766453.4T
Other languages
English (en)
Inventor
Eric Horn
Steven Fairway
Dimitrios Mantzilas
Nigel Powell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2509637T3 publication Critical patent/PL2509637T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
PL10766453.4T 2009-10-08 2010-10-08 Sposób oczyszczania PL2509637T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24965609P 2009-10-08 2009-10-08
US28523909P 2009-12-10 2009-12-10
US31550710P 2010-03-19 2010-03-19

Publications (1)

Publication Number Publication Date
PL2509637T3 true PL2509637T3 (pl) 2016-12-30

Family

ID=43662087

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10766453.4T PL2509637T3 (pl) 2009-10-08 2010-10-08 Sposób oczyszczania

Country Status (15)

Country Link
US (2) US8969580B2 (pl)
EP (1) EP2509637B1 (pl)
AU (1) AU2010303355B2 (pl)
CA (1) CA2785179C (pl)
DK (1) DK2509637T3 (pl)
EA (1) EA023197B1 (pl)
ES (1) ES2598284T3 (pl)
HU (1) HUE030813T2 (pl)
IL (2) IL220559A0 (pl)
NZ (1) NZ600791A (pl)
PL (1) PL2509637T3 (pl)
PT (1) PT2509637T (pl)
SG (2) SG2014012686A (pl)
WO (2) WO2011044406A2 (pl)
ZA (1) ZA201205580B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585567B2 (en) 2011-11-16 2017-03-07 Koninklijke Philips N.V. Method to compute and present brain amyloid in gray matter
GB201120586D0 (en) * 2011-11-30 2012-01-11 Ge Healthcare Ltd Solid phase extraction neutralisation
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
GB201223178D0 (en) 2012-12-21 2013-02-06 Ge Healthcare Ltd Dose recordal
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
EP3036209B1 (en) * 2013-08-22 2018-08-01 GE Healthcare Limited An improved synthesis of [18f]- fluoroalkyl tosylate
GB201420093D0 (en) 2014-11-12 2014-12-24 Ge Healthcare Ltd Pet tracer purification system
EP3226884B1 (en) 2014-12-04 2021-02-17 GE Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
JP6485914B2 (ja) * 2015-10-28 2019-03-20 日本メジフィジックス株式会社 フルテメタモルの製造方法
GB201621864D0 (en) * 2016-12-21 2017-02-01 Ge Healthcare Ltd Solid phase conditioning
JP6955347B2 (ja) * 2017-02-28 2021-10-27 日本メジフィジックス株式会社 フルテメタモルの製造方法
JP7100841B2 (ja) * 2018-03-07 2022-07-14 日本メジフィジックス株式会社 放射性医薬組成物の製造方法
WO2020046923A1 (en) * 2018-08-27 2020-03-05 Dana-Farber Cancer Institute, Inc. Modular radio-labeling tracer synthesizer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19809960C2 (de) * 1998-03-07 2002-09-19 Forschungszentrum Juelich Gmbh Verfahren zur Herstellung von [·1··5·O]Butanol und Vorrichtung zur Durchführung des Verfahrens
DK2182988T3 (da) * 2007-08-30 2014-05-26 Ge Healthcare Ltd Radiofarmaceutisk præparat

Also Published As

Publication number Publication date
ES2598284T3 (es) 2017-01-26
WO2011044406A3 (en) 2011-06-23
SG182378A1 (en) 2012-08-30
WO2011044406A2 (en) 2011-04-14
SG2014012686A (en) 2014-06-27
EP2509637A2 (en) 2012-10-17
US20150259307A1 (en) 2015-09-17
NZ600791A (en) 2014-02-28
EP2509637B1 (en) 2016-08-10
CA2785179C (en) 2018-06-05
IL243248A0 (en) 2016-02-29
WO2011044410A3 (en) 2011-06-23
IL220559A0 (en) 2012-08-30
DK2509637T3 (en) 2016-10-10
EA023197B1 (ru) 2016-05-31
US9346771B2 (en) 2016-05-24
HUE030813T2 (en) 2017-05-29
PT2509637T (pt) 2016-10-05
US8969580B2 (en) 2015-03-03
AU2010303355B2 (en) 2015-09-03
ZA201205580B (en) 2013-04-24
CA2785179A1 (en) 2011-04-14
WO2011044410A2 (en) 2011-04-14
EA201290424A1 (ru) 2012-11-30
AU2010303355A1 (en) 2012-08-16
US20130012718A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
GB0905140D0 (en) Method
GB0911905D0 (en) Method
IL243248A0 (en) Purification method
GB0902476D0 (en) Method
GB0910707D0 (en) Method
GB0913525D0 (en) Method
GB0918940D0 (en) Method
GB0913433D0 (en) Method
GB0901444D0 (en) Method
GB0921375D0 (en) Method
GB0905367D0 (en) Method
GB0903316D0 (en) Method
GB0917457D0 (en) Method
GB0916570D0 (en) Method
GB0908770D0 (en) Method
GB0916013D0 (en) Method
GB0920596D0 (en) Method
GB0917988D0 (en) Method
GB0902034D0 (en) Method
GB0900560D0 (en) Method
GB0911362D0 (en) Method
GB0904946D0 (en) Method
GB0920089D0 (en) Method
GB0919901D0 (en) Method
GB0914702D0 (en) Method